Grow your business safely with Sharon Pharma

All the information you need about Sharon Pharma to develop and secure your business in France

S HOME > CORPORATES > Sharon Pharma > BALANCE SHEET ( 2017-07-05)

THE LIST OF BALANCE SHEET : Sharon Pharma

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2018-06-14 Public 2017-12-31 Complete
2017-07-05 Public 2016-12-31 Complete
NameSharon Pharma
Siren803590975
Closing2016-12-31
Registry code 7501
Registration number 48317
Management number2014D03246
Activity code 4773Z
Closing date n-12015-12-31
Duration Fiscal year 12
Duration Fiscal year n-118
Filing date2017-07-05
Modification01 Annual accounts entered with accounting inconsistencies at document source
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address75004 PARIS
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AB Establishment Expenses 55 000.00 26 845.00 28 155.00 55 000.00
AH Goodwill 230 000.00 230 000.00 230 000.00
AT Other tangible assets 90 006.00 11 450.00 78 556.00 90 006.00
BH Other financial assets 16 000.00 16 000.00 16 000.00
BJ TOTAL (I) 391 006.00 38 295.00 352 711.00 391 006.00
BT Goods 127 363.00 127 363.00 127 363.00
BZ Other receivables 12 586.00 12 586.00 12 586.00
CF Cash and cash equivalents 113 532.00 113 532.00 113 532.00
CJ TOTAL (II) 253 480.00 253 480.00 253 480.00
CO Grand total (0 to V) 644 487.00 38 295.00 606 192.00 644 487.00
CP Shares due in less than one year 16 000.00 16 000.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 10 000.00 10 000.00 10 000.00
DH Retained earnings 46 826.00 46 826.00
DI RESULTS FOR THE YEAR (Profit or Loss) 25 242.00 46 826.00 25 242.00
DL TOTAL (I) 82 068.00 56 826.00 82 068.00
DU Loans and Debts from Credit Institutions (3) 307 435.00 290 128.00 307 435.00
DV Miscellaneous Loans and Financial Debts (4) 209.00 11 286.00 209.00
DX Trade payables and related accounts 186 366.00 176 227.00 186 366.00
DY Tax and social security liabilities 30 114.00 21 676.00 30 114.00
EC TOTAL (IV) 524 124.00 499 317.00 524 124.00
EE Grand total (I to V) 606 192.00 556 143.00 606 192.00
EG Accrued income and payables due within one year 513 845.00 485 165.00 513 845.00
EH Including current bank overdrafts and credit balances from banks and postal accounts 64 747.00 64 747.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FA Sales of goods 126 021.00 556 792.00 682 813.00 126 021.00
FD Production sold - goods
FJ Net sales 126 021.00 556 792.00 682 813.00 126 021.00
FQ Other income 17.00
FR Total operating income (I) 682 829.00
FS Purchases of goods (including customs duties) 412 361.00
FT Inventory change (goods) 13 465.00
FW Other purchases and external expenses 88 732.00
FX Taxes, duties, and similar payments 1 849.00
FY Salaries and Wages 77 940.00
FZ Social Security Contributions 39 906.00
GA Operating Expenses - Depreciation and Amortization 16 392.00
GE Other Expenses 7.00
GF Total Operating Expenses (II) 650 651.00
GG - OPERATING RESULT (I - II) 32 178.00
GR Interest and similar expenses 2 800.00
GU Total financial expenses (VI) 2 800.00
GV - FINANCIAL INCOME (V - VI) -2 800.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 29 379.00
4 - Income statement (continued)Amount year NAmount year N-1
A2 TOTAL ASSETS 3 372.00 2 110.00 3 372.00
HE Exceptional expenses on management operations 243.00 243.00
HH Total exceptional expenses (VIII) 243.00 243.00
HI - EXCEPTIONAL RESULT (VII - VIII) -243.00 -243.00
HK Income tax 3 894.00 7 608.00 3 894.00
HL TOTAL REVENUE (I + III + V + VII) 682 829.00 805 047.00 682 829.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 657 588.00 758 221.00 657 588.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 25 242.00 46 826.00 25 242.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 114 706.00 30 300.00 114 706.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 55 000.00 55 000.00
I4 DECREASES Grand Total 145 006.00
IN DECREASES Start-up, development, or research expenses 55 000.00
IY DECREASES Total Tangible Fixed Assets 90 006.00
LN ACQUISITIONS Total Tangible Fixed Assets 59 706.00 30 300.00 59 706.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 21 903.00 16 392.00 21 903.00
CY DEPRECIATION Start-up, development, or research expenses 15 845.00 11 000.00 15 845.00
QU DEPRECIATION Total Tangible Fixed Assets 6 058.00 5 392.00 6 058.00

all companies in France

Complete and comprehensive database.